Lv3
288 积分 2023-02-20 加入
Decoupling the dynamic mechanism revealed by FGFR2 mutation-induced population shift
1个月前
已完结
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
1个月前
已完结
Familial endometrial cancer in female carriers of MSH6 germline mutations
1个月前
已完结
Novel rearrangements involving the RET gene in papillary thyroid carcinoma
3个月前
已完结
Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report
3个月前
已完结
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
5个月前
已完结
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
5个月前
已完结
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?
5个月前
已完结
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
5个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
6个月前
已完结
皖公网安备34019202002308
